股票定增
Search documents
A股定增一览(1月21日):4家公司披露定增进展
Di Yi Cai Jing· 2026-01-21 00:09
Group 1 - On January 21, a total of 4 companies in the A-share market announced plans related to private placements, with 2 companies disclosing new private placement proposals and 2 companies having their proposals approved by the exchange [1] - The highest proposed fundraising amounts from the newly disclosed private placement plans are from Jinma Amusement and Jincai Internet, with proposed amounts not exceeding 1.053 billion yuan and 570 million yuan, respectively [1] - Since the beginning of the year, 9 companies have announced completed private placement plans, with 4 companies raising over 1 billion yuan. Specifically, the highest fundraising amounts were from Shanggong Electric, Shensangda A, and Taisheng Wind Energy, raising 1.649 billion yuan, 1.2 billion yuan, and 1.176 billion yuan, respectively [1]
冠石科技连亏2年 正拟不超7亿元定增2021年上市募5亿元
Zhong Guo Jing Ji Wang· 2026-01-20 03:27
Group 1 - The core viewpoint of the news is that Guanshi Technology (605588.SH) has released its performance forecast for 2025, indicating an expected net loss for the year, which is an increase compared to the previous year [1] - For 2024, Guanshi Technology reported an operating income of 1.359 billion yuan, representing a year-on-year growth of 51.95%, but also a net loss attributable to shareholders of 15.45 million yuan, compared to a profit of 52.22 million yuan in the previous year [1] - The company anticipates a net profit attributable to shareholders for 2025 to be between -84 million yuan and -56 million yuan, with a net profit excluding non-recurring gains and losses expected to be between -102 million yuan and -68 million yuan [1] Group 2 - Guanshi Technology raised a total of 501 million yuan from its initial public offering, with a net amount of 456 million yuan after deducting issuance costs, which were primarily allocated for functional structural components, ultra-high-definition liquid crystal display panels, and a research and development center [2] - The total issuance costs for the IPO amounted to 45.23 million yuan, including underwriting fees of 30.07 million yuan [2] - The company plans to raise up to 700 million yuan through a specific issuance of stocks in 2026, with the net proceeds intended for a photomask manufacturing project and to supplement working capital [2]
今日看点|国新办将举行货币金融政策支持实体经济高质量发展成效新闻发布会
Jing Ji Guan Cha Bao· 2026-01-15 01:48
Group 1 - The State Council Information Office will hold a press conference on January 15 to discuss the effectiveness of monetary and financial policies in supporting the high-quality development of the real economy [1] - The Ministry of Commerce will also hold a press conference on January 15 to introduce recent key work in the business sector [2] Group 2 - The People's Bank of China will conduct a 900 billion yuan reverse repurchase operation on January 15 to maintain ample liquidity in the banking system, with a term of 6 months (181 days) [3] Group 3 - On January 15, a total of 9 companies will have their restricted shares unlocked, with a total unlock volume of 304 million shares, amounting to a market value of 15.476 billion yuan [4] - The companies with the largest unlock volumes include Hanma Technology, Zhongke Lanyun, and Huitong Technology, with unlock shares of 140 million, 76.2838 million, and 52.872 million respectively [4] - The companies with the highest unlock market values are Zhongke Lanyun, Huitong Technology, and Sikan Technology, with values of 10.97 billion, 1.529 billion, and 1.344 billion yuan respectively [4] Group 4 - On January 15, 11 companies disclosed progress on stock repurchases, with one company’s repurchase plan approved by the shareholders' meeting and nine companies completing their repurchase plans [5] - Yuheng Pharmaceutical has the highest proposed repurchase amount of up to 2.7 million yuan, while Kaifa Electric has completed a repurchase of 4.2068 million yuan [5] Group 5 - Five companies disclosed progress on private placements on January 15, with four companies announcing private placement plans and one plan approved by the exchange [6] - The highest proposed fundraising amounts are from *ST Songfa and Lante Optics, with amounts of up to 7 billion and 1.055 billion yuan respectively [6] Group 6 - Ten A-shares will undergo equity registration on January 15, with all ten companies planning to distribute dividends [7] - The companies with the largest dividend payouts are China Merchants Bank, Huayan Precision Machinery, and Industrial Fulian, with payouts of 10.13 yuan, 5.00 yuan, and 3.30 yuan per 10 shares respectively [7]
连亏股德龙激光拟定增 实控人及二三大股东年内均减持
Zhong Guo Jing Ji Wang· 2025-12-30 06:49
Core Viewpoint - Delong Laser (688170.SH) plans to issue shares to raise up to RMB 240 million for the construction of a laser production project and a headquarters R&D center [1][3]. Group 1: Share Issuance Details - The total amount to be raised from the share issuance is capped at RMB 240 million, which is not more than 20% of the company's net assets as of the end of the previous year [1][3]. - The share issuance will be conducted through a simplified procedure targeting specific investors, including qualified institutional investors and individuals, with a maximum of 35 participants [2][4]. - The shares will be ordinary A-shares with a par value of RMB 1.00 each, and the issuance price will be set at no less than 80% of the average trading price over the last 20 trading days prior to the pricing date [4]. Group 2: Project Investment Breakdown - The planned investment for the laser production project is RMB 174.50 million, with RMB 170 million sourced from the raised funds [3]. - The headquarters R&D center project has a total investment of RMB 73.01 million, with RMB 70 million allocated from the raised funds [3]. - The combined total investment for both projects is RMB 247.51 million, with the total amount to be raised being RMB 240 million [3]. Group 3: Company Financial Performance - In 2024, the company reported revenue of RMB 715 million, a year-on-year increase of 22.93%, but a net loss of RMB 34.50 million compared to a profit of RMB 39.05 million in the previous year [7]. - For the first nine months of 2025, the company achieved revenue of RMB 451 million, an 8.45% increase year-on-year, but continued to report a net loss of RMB 16.86 million [7].
永创智能不超3亿定增获上交所审核通过 浙商证券建功
Zhong Guo Jing Ji Wang· 2025-12-30 06:08
Core Viewpoint - Yongchun Intelligent has received approval from the Shanghai Stock Exchange for its application to issue shares to specific investors through a simplified procedure, pending final approval from the China Securities Regulatory Commission (CSRC) [1] Group 1: Fundraising Details - The company plans to raise a total of 299,999,991.23 yuan, not exceeding 30 million yuan, with the net proceeds allocated to a project for producing 3,500 sets of digital intelligent solid food packaging equipment and to supplement working capital [1][2] - The total investment for the digital intelligent solid food packaging equipment project is 232.87 million yuan, with 216.58 million yuan expected to be funded from the raised capital [2] Group 2: Issuance and Subscription - The issuance will involve up to 35 specific investors, all subscribing in cash, with no related party transactions involved [2] - The total number of shares to be issued is 26,572,187, with a determined issue price of 11.29 yuan per share, which is not less than 80% of the average stock price over the previous 20 trading days [3][4] Group 3: Shareholding Structure - Before the issuance, the actual controllers of Yongchun Intelligent, Luo Bangyi and Lü Jie, hold a combined 50.28% of the shares. Post-issuance, their combined control will decrease to 47.68%, but they will remain the actual controllers of the company [5]
北摩高科拟定增股票募资不超19.7亿元
Zhi Tong Cai Jing· 2025-12-29 12:41
北摩高科(002985)(002985.SZ)发布2025年度向特定对象发行A股股票预案,本次向特定对象发行募集 资金总额不超过人民币19.7亿元(含本数),扣除发行费用后的募集资金净额将用于以下项目:起降系统 产能扩建项目、民航产品产业化项目、民航大飞机适航保障能力提升项目以及补充流动资金。 ...
逾55万手封单!002387“一字”涨停,控制权拟变更
Zheng Quan Shi Bao Wang· 2025-11-10 03:31
New IPOs - This week, two new stocks are available for subscription: Nant Technology on Tuesday and Hai'an Group on Friday [1] - Nant Technology specializes in the research, production, and sales of precision mechanical components, with applications in air conditioning compressor parts and automotive components [1] - Hai'an Group focuses on the research, production, and sales of giant all-steel engineering machinery radial tires and the operation management of mining tires [1] Private Placement Announcements - Three companies have recently announced private placement plans, with Yintan Zhikong and Visionox hitting the daily limit up on the opening day [3] - Visionox plans to issue up to 419 million shares at a price of 7.01 yuan, aiming to raise approximately 2.937 billion yuan, which will result in a change of control as Hefei Jianshu will become the controlling shareholder [3] - Yintan Zhikong intends to acquire 100% of Guanglong Group's shares in Guanglong Integrated and 80% of Aojian Microelectronics from several shareholders, with the transaction expected to enhance its subsidiary structure [5] Margin Financing Activity - As of November 7, the total market margin balance is 2.48 trillion yuan, a decrease of 50.22 billion yuan from the previous trading day [7] - On November 7, 447 stocks had a net margin buy-in of over 10 million yuan, with 35 stocks exceeding 100 million yuan [7] - Tianfu Communication led the net buy-in with 1.491 billion yuan, followed by Tongwei Co. and Longi Green Energy with 433 million yuan and 419 million yuan, respectively [8]
11月8日9家公司披露定增进展
Xin Lang Cai Jing· 2025-11-08 01:17
Core Insights - On November 8, a total of 9 companies in the A-share market announced related plans for private placements [1] - Among these, 2 companies disclosed new private placement proposals, while 3 proposals were approved by shareholders' meetings [1] - 1 proposal received approval from the stock exchange, and another from the China Securities Regulatory Commission (CSRC) [1] - 2 private placement plans were halted [1] - Xi'an Tourism has the highest proposed fundraising amount, aiming to raise no more than 300 million yuan [1]
泉峰汽车连亏3年1期 正拟定增2019年上市3募资共23亿
Zhong Guo Jing Ji Wang· 2025-09-02 07:31
Core Viewpoint - The financial performance of QuanFeng Automotive shows improvement in revenue but continues to face net losses, indicating ongoing challenges in profitability despite revenue growth [1][5]. Financial Performance Summary - For the first half of 2025, QuanFeng Automotive reported revenue of 1.218 billion yuan, an increase of 18.90% year-on-year [1]. - The net profit attributable to shareholders was -167 million yuan, an improvement from -254 million yuan in the same period last year [1]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -173 million yuan, compared to -242 million yuan in the previous year [1]. - The net cash flow from operating activities was 19.62 million yuan, a significant recovery from -168 million yuan in the same period last year [1]. Historical Financial Data - From 2022 to 2024, the company reported revenues of 1.745 billion yuan, 2.135 billion yuan, and 2.303 billion yuan respectively [1]. - The net profits attributable to shareholders for the same years were -154 million yuan, -565 million yuan, and -517 million yuan [1]. - The net cash flow from operating activities for these years was -527 million yuan, -328 million yuan, and 138 million yuan respectively [1]. Fundraising Activities - QuanFeng Automotive raised a total of 4.895 million yuan from its initial public offering, with a net amount of 4.524 million yuan allocated for production and working capital [2]. - In 2021, the company issued convertible bonds totaling 620 million yuan, with a net amount received of approximately 610.47 million yuan after expenses [2]. - In 2022, the company conducted a non-public offering of shares, raising approximately 1.193 billion yuan, with a net amount of about 1.178 billion yuan after deducting issuance costs [3]. Upcoming Fundraising Plans - The company plans to issue shares to specific investors, aiming to raise up to 200 million yuan, with proceeds intended for working capital and bank loan repayment [4]. - The issuance price is set at 7.82 yuan per share, which is 80% of the average trading price over the previous 20 trading days [4]. - The approval from the China Securities Regulatory Commission is still pending, introducing uncertainty regarding the execution of this fundraising plan [5].
欧林生物终止定增 拟现金买新诺明15%股权上市即巅峰
Zhong Guo Jing Ji Wang· 2025-09-01 07:33
Core Viewpoint - 欧林生物 has decided to terminate its plan for a simplified procedure to issue A-shares to specific investors and has withdrawn the application due to current market conditions and company circumstances [1] Group 1: Termination of Share Issuance - The company held its seventh board meeting on August 29, 2025, where it approved the termination of the A-share issuance plan [1] - The decision was made after careful analysis of various factors, including market conditions and the company's development plans [1] - The termination of the share issuance will not significantly impact the company's daily operations or harm the interests of the company and its shareholders [1] Group 2: Previous Issuance Plan Details - The previous plan aimed to raise up to RMB 300 million, with a maximum of 20% of the company's net assets from the previous year [2] - The funds were intended for the vaccine research and production base renovation project, with a total investment of RMB 290 million [3] - The planned issuance involved 9,138,795 shares at a price of RMB 13.71 per share, representing up to 30% of the company's total share capital before the issuance [4] Group 3: Shareholder Structure and Control - Shanghai Wushan is the controlling shareholder, holding 17.83% of the company's shares, while the actual controllers are 樊绍文 and 樊钒, who collectively control 29.22% of the voting rights [5] - After the planned issuance, the actual controllers would hold 28.58% of the voting rights, indicating no change in control [5] Group 4: Acquisition of Minority Stake - The company plans to acquire a total of 15% of the minority shares in its subsidiary, 新诺明生物, through a public transfer at a price not exceeding RMB 45 million [6] - This acquisition does not constitute a major asset restructuring and does not involve related transactions [6]